GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
297 hedge funds and large institutions have $5.23B invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 116 funds opening new positions, 37 increasing their positions, 84 reducing their positions, and 94 closing their positions.
425% more funds holding in top 10
Funds holding in top 10: 4 → 21 (+17)
90% more capital invested
Capital invested by funds: $2.75B → $5.23B (+$2.48B)
23% more first-time investments, than exits
New positions opened: 116 | Existing positions closed: 94
6% more funds holding
Funds holding: 279 → 297 (+18)
24% less call options, than puts
Call options by funds: $83M | Put options by funds: $110M
56% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 84
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$395M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$282M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
+$253M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$240M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$184M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$694M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$465M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$360M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$286M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$173M |
GWPH Hedge Fund Activity: Q1 2021 in Review
297 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2021, worth a combined $5.23B — up 90% from $2.75B a quarter earlier.
Buyers outnumbered sellers: 116 funds opened new GWPH positions and 94 closed out — a net gain of 22 holders — while 37 added to existing stakes and 84 trimmed.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $395M. The largest seller was Capital Research Global Investors, cutting an estimated $694M.
- 297 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2021, up from 279 in Q4 2020.
- Funds reported $5.23B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2021, up 90% quarter-over-quarter.
- 116 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2021 and 94 closed out, a net change of +22 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2021 was Pentwater Capital Management, an estimated $395M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2021 was Capital Research Global Investors, an estimated $694M sold.
Based on aggregated 13F filings for Q1 2021.